The Penn State Cancer Institute is a cancer research center of the Penn State Milton S. Hershey Medical Center located in Hershey, Pennsylvania. The Institute provides clinical care, research, education, and community outreach services throughout central and eastern Pennsylvania.

During the past decade, Penn State Cancer Institute at Milton S. Hershey Medical Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 38 clinical trials were completed, i.e. on average, 105.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State Cancer Institute at Milton S. Hershey Medical Center" #1 sponsor was "Children's Oncology Group" with 30 trials, followed by "Eastern Cooperative Oncology Group" with 23 trials sponsored, "Milton S. Hershey Medical Center" with 22 trials sponsored, "Radiation Therapy Oncology Group" with 18 trials sponsored and "Gynecologic Oncology Group" with 18 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Cancer Institute at Milton S. Hershey Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 106 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Big Ten Cancer Research Consortium" with 6 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Penn State Cancer Institute at Milton S. Hershey Medical Center" are "Lymphoma" (14 trials), "Leukemia" (13 trials), "Lung Cancer" (12 trials), "Sarcoma" (11 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "Penn State Cancer Institute at Milton S. Hershey Medical Center" in a lesser frequency.

Most popular intervention types in "Penn State Cancer Institute at Milton S. Hershey Medical Center" are "Drug" (121 trials), "Biological" (44 trials), "Radiation" (43 trials), "Procedure" (38 trials) and "Other" (16 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (31 trials), "cyclophosphamide" (24 trials), "filgrastim" (22 trials), "cisplatin" (16 trials) and "etoposide" (15 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Cancer Institute at Milton S. Hershey Medical Center" are 127 trials for "All" genders, 24 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Penn State Cancer Institute at Milton S. Hershey Medical Center". undefined are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Penn State Cancer Institute at Milton S. Hershey Medical Center, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Cancer Institute at Milton S. Hershey Medical Center, 18 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".